Revel Health Reviews: Clear Pricing, Unnamed Pharmacy

The one-sentence version

Revel Health does something few providers here manage cleanly: it publishes an ongoing monthly price for NAD+ and sermorelin, states outright that "pricing remains consistent regardless of dosage," and separates the first-month discount from the standing rate instead of blending them into one misleading number. What it does not do is name a pharmacy — prescriptions route through an unnamed "Pharmacy Network," with no facility and no 503A/503B classification stated anywhere we could find. It grades B, 10 out of 14, computed from published terms alone. We hold no affiliate relationship with Revel today.

What it is, and who it's for

Revel Health Inc. runs myrevelhealth.com, a telehealth platform organized around four sections — Longevity, Weight Loss, Energy & Vitality, and Recovery & Performance. Its own positioning: "For those thinking about the next 20 years — not just the next 20 pounds." The catalog spans compounded semaglutide and tirzepatide alongside NAD+ and sermorelin injections. Medical care is delivered through "a contracted network of physicians licensed in the state where you reside" — Revel Health itself states it "does not provide medical services." Coverage is 45 states, published outright on its own FAQ: everywhere except AK, AR, NC, NJ and MS.

What it actually costs

The pricing cards on the homepage read cleanly: NAD+ Injection, "From $169/mo," first month $119. Sermorelin Injection, "From $149/mo," first month $99. Semaglutide is "From $199/mo" (first month $99) and tirzepatide "From $249/mo" (first month $149).

The "From" qualifier is resolved, not left hanging. Its FAQ states directly: "Pricing remains consistent regardless of dosage. You can choose a monthly option or a one-time purchase, depending on what works best for you." That is a direct answer to the exact ambiguity that undercuts other rows here — Winona's Estrogen Patch, for instance, is "From $149/mo" across five dose strengths with no statement on whether a higher dose costs more. Revel closes that gap in its own words, even if the storefront card itself still carries the word "From."

Billing is genuinely monthly, not a disguised prepay. Its Terms of Service state: "If you enroll in a monthly subscription, you authorize us to charge your payment method on a recurring monthly basis at the then-current monthly price until you cancel." Cancel any time before the next billing date and future charges stop.

The refund policy is more structured than most providers here bothers to publish, laid out in three tiers:

• •A. Not approved — full refund. "If a provider determines that you are not approved for treatment, and no medication order has been submitted to a pharmacy for fulfillment, you are eligible for a full refund of the applicable charge for that purchase period."
• •B. Cancel before pharmacy submission — refund eligible. "You may request to cancel an order before it is submitted to a pharmacy... you may be eligible for a refund for that purchase period."
• •C. Order submitted to pharmacy — no refund. "Once an order has been submitted to a pharmacy, compounded, dispensed, shipped, or otherwise entered fulfillment, charges are non-refundable, except where required by law."

That is a genuinely fair structure: you know exactly which side of the line you're on, and the "not approved" case — the one that matters most before you've committed — is a clean full refund with the subscription itself canceled, "so there are no ongoing charges."

Clinical oversight and the pharmacy

A licensed provider reviews every intake before anything ships; Revel Health states plainly that approval "is not guaranteed" and that treatment decisions rest with "independent licensed providers," not with the company.

The gap is pharmacy transparency. Its own Terms describe only a "Pharmacy Network" — "you may select one of the pharmacies we contract with... to ship your prescription" — with no individual facility named and no 503A or 503B classification stated on any page we checked. Under our rubric, an unnamed network scores at the bottom of this factor, the same rung as several other rows here despite Revel's real strengths elsewhere.

The evidence behind what it sells

The two products this ranking grades here — NAD+ and sermorelin — sit at very different distances from proof, and neither is close.

A 2026 PRISMA-guided systematic review screened 113 studies including 33 human intervention trials and found that oral NAD+ precursors reliably raise NAD+ levels and are well tolerated, but that effects on functional, metabolic and vascular outcomes were heterogeneous and often null, with clinical effectiveness for anti-aging "inconclusive." Directly relevant to an injectable product: no eligible outcomes trial evaluated intravenous or intramuscular NAD+ itself for anti-aging or wellness¹.

Sermorelin is a growth-hormone-releasing analog, and the class raises the hormone while the outcomes remain the open question. The standing systematic review of growth hormone in healthy older adults found small body-composition changes — a little more lean mass, a little less fat — with no demonstrated improvement in the outcomes people buy it for, alongside higher rates of soft-tissue edema, joint pain and impaired fasting glucose².

Both are compounded, and FDA is explicit that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before marketing³.

Where it's weak, and who should skip it

Skip it if pharmacy transparency matters most to you — Taurus Meds and Telos Rx both name their dispensing facilities with addresses; Revel does not. Skip it if you want ongoing dose-adjustment support spelled out explicitly — we found no stated claim of unlimited messaging or scheduled check-ins beyond the initial intake review. Otherwise, the pricing itself is close to a model for this site: a real number, resolved of its dose ambiguity in the FAQ, with a fair and specific refund policy behind it.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Revel takes all four for price — a real, dose-independent monthly figure with the introductory rate clearly separated from the standing one. Four for a genuine longevity line: NAD+ and sermorelin sit alongside GLP-1s, not bolted on as an afterthought. Two for licensed-provider review before anything ships. Zero on pharmacy — an unnamed network, no facility, no classification. Zero on human support — no stated ongoing-messaging claim. Ten of fourteen: a B, at the top of the band.

Name the pharmacy network's facilities, or state a 503A/503B standard on the site, and this row is arguing for an A on the strength of its pricing alone. Neighbors worth reading next are the Taurus Meds review and System Labs review, both NAD+/peptide providers with very different pricing transparency, and our Wellspring Longevity Clinic review for a provider that names its pharmacy but hides its price, the reverse problem; the full field is at our provider rankings.